Research Journal of Oncology Open Access

  • Journal h-index: 4
  • Journal CiteScore: 0.30
  • Journal Impact Factor: 0.24
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days

Shihori Tanabe

Shihori Tanabe
National Institute of Health Sciences, Japan


Senior Researcher, Division of Risk Assessment, Biological Safety Research Center, National Institute of Health Sciences?(Apr 2016 -Present, Kawasaki, Japan) In Concurrent with Director for Planning and Coordination?s (Apr 2011 ?Mar 2016) Senior Researcher, Division of Safety Information on Drug, Food and Chemicals, National Institute of Health Sciences?(Apr 2010-?Mar 2016, Tokyo, Japan) In Concurrent with Health Sciences Division, Minister?s Secretariat, Ministry of Health, Labour and Welfare (Apr 2009-Sep 2010, Tokyo, Japan) Researcher, Division of Cellular and Gene Therapy Products, National Institute of Health Sciences (Feb 2006-Mar 2010, Tokyo, Japan) Post Doctoral Fellow, Researcher, Laboratory of Cell Signaling, Graduate School of Pharmaceutical Sciences, The University of Tokyo (Apr 2005-Jan 2006, Tokyo, Japan)

Research Interest

She is interested in finding essential factors to distinguish cancer and stem cell types for revealing mechanism of cancer development and safe application of the cells as cellular therapeutics in regenerative medicine, as well as in assessing the long-term influences of the alteration in gene expression and cellular phenotype from the point of view of regulatory science. She is a delegate for the Japanese Society for Regenerative Medicine, a councilor for Society for Regulatory Science of Medical Products, and an editorial board member for Journal of Toxicological Sciences, Fundamental Toxicological Sciences, World Journal of Stem Cells, World Journal of Gastrointestinal Oncology, and Journal of Medical Genomics and Biomarkers.